http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106478571-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b10decb300a35a1ded0e0ea15f8de05c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93 |
| filingDate | 2016-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75855614ca7964de1e727eb5f14734a |
| publicationDate | 2017-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106478571-A |
| titleOfInvention | A kind of pharmaceutical composition of leflunomide and its medical usage |
| abstract | The invention discloses a kind of pharmaceutical composition of leflunomide and its medical usage, containing the natural products compound (I) that leflunomide and a kind of structure are novel in the pharmaceutical composition of the leflunomide that the present invention is provided, when leflunomide, compound (I) independent role, there is therapeutic action to cholelithiasis；When leflunomide and compound (I) synergy, the therapeutic effect to cholelithiasis is significantly improved, and can be developed into the medicine for the treatment of cholelithiasis, has prominent substantive distinguishing features compared with prior art progressive with significant. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105924413-A |
| priorityDate | 2016-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.